10X Genomics (TXG) PT Raised to $70 at Morgan Stanley

October 13, 2026 8:22 AM

Morgan Stanley analyst Kallum Titchmarsh raised the price target on 10X Genomics (NASDAQ: TXG) to $70.00 (from $40.00) while maintaining a Equalweight rating.

No results found